Literature DB >> 26488944

Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma.

Matthew K Stein1, Bryant B Summers, Christine A Wong, Hilary L Box, Kerry O Cleveland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26488944     DOI： 10.1097/MAJ.0000000000000584

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  7 in total

Review 1.  Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors.

Authors:  Dustin Anderson; Grayson Beecher; Nabeela Nathoo; Michael Smylie; Jennifer A McCombe; John Walker; Rajive Jassal
Journal:  Neurooncol Pract       Date:  2018-10-04

Review 2.  Checkpoint Inhibitors.

Authors:  Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal:  Dtsch Arztebl Int       Date:  2019-02-22       Impact factor: 5.594

3.  Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma.

Authors:  Simon Bossart; Selina Thurneysen; Elisabeth Rushing; Karl Frontzek; Henning Leske; Daniela Mihic-Probst; Hannes W Nagel; Johanna Mangana; Simone M Goldinger; Reinhard Dummer
Journal:  Oncologist       Date:  2017-05-30

Review 4.  Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management.

Authors:  Christophoros Astaras; Rita de Micheli; Bianca Moura; Thomas Hundsberger; Andreas F Hottinger
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-01       Impact factor: 5.081

5.  Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.

Authors:  Laure Thouvenin; Timothée Olivier; Giuseppe Banna; Alfredo Addeo; Alex Friedlaender
Journal:  Ther Adv Drug Saf       Date:  2021-03-29

Review 6.  Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention.

Authors:  Benxia Zhang; Xue Li; Tao Yin; Diyuan Qin; Yue Chen; Qizhi Ma; Pei Shu; Yongsheng Wang
Journal:  J Oncol       Date:  2022-01-18       Impact factor: 4.375

Review 7.  Immune Checkpoint Inhibitors and Neurotoxicity.

Authors:  Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.